Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys

Atherosclerosis

Volumn 138, Issue 1, 1998, Pages 171-182

  Song, Keifu ^a   Shiota, Naotaka ^a   Takai, Sinji ^a   Takashima, Hiroki ^b   Iwasaki, Hitoshi ^b   Kim, Shokei ^c   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Department of Drug Metabolism   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme; Angiotensin II; Atherosclerosis; Fibronectin; Gene expression; Inhibitors; Receptors; Transforming growth factor

Indexed keywords

ANGIOTENSIN; FIBRONECTIN; IMIDAPRIL; MESSENGER RNA;

ANIMAL EXPERIMENT; AORTA ATHEROSCLEROSIS; ARTICLE; CHOLESTEROL DIET; DRUG EFFECT; ENZYME ACTIVITY; MALE; MONKEY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RECEPTOR DENSITY; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; COLLAGEN; FIBRONECTINS; IMIDAZOLES; IMIDAZOLIDINES; MACACA FASCICULARIS; MALE; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032076333     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00021-5     Document Type: Article

References (52)

1. Chovanian AV, Haudenschild CC, Nickerson C, Drago R Antiatherogenic effect of captopril in Watanabe heritable hyperlipidemic rabbit. Hypertension. 15:1990;327-331.
2. Chovanian AV, Haudenschild CC, Nickerson C, Hope S Trandorapril inhibits atherosclerosis in Watanabe heritable hyperlipidemic rabbit. Hypertension. 20:1992;473-477.
3. Aberg G, Ferrer P Effects of captopril on atherosclerosis in Cynomolgus monkeys. J Cardiovasc Pharmacol. 15(suppl 5):1990;S65-S72.
4. Campbell J, Fenessey P, Campbell GR Effect of perindopril on the development of atherosclerosis in the cholesterol fed rabbit. Clin Exp Pharmacol Physiol. 19(suppl 19):1992;13-17.
5. Jacobsson L, Persson K, Aberg G, Andersson RG, Kalberg BE, Olisson AG Antiatherosclerotic effects of the angiotensin converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs. J Cardiovasc Pharmacol. 24:1994;670-677.
6. Kowala MC Captopril decreases accelerated atherosclerosis in hypertensive one kidney one clip rats fed cholesterol. Drug Dev Res. 29:1993;100-108.
7. Kowala MC, Grove RI, Aberg G Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. Atherosclerosis. 108:1994;61-71.
8. Ross R The pathogenesis of atherosclerosis: a perspective for 1990s. Nature. 362:1993;801-809.
9. Berk BC, Vekstein V, Gordon HM, Tsuda T Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 13:1989;305-314.
10. Geisterfer AAT, Peach MJ, Owens GK Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat smooth muscle cells. Circ Res. 62:1988;749-756.
11. Gibbons GH, Pratt RE, Dzau VJ Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor beta determines response to angiotensin II. J Clin Invest. 90:1992;456-461.
12. Weber H, Taylor DS, Molloy CJ Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. J Clin Invest. 93:1994;788-798.
13. Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B Angiotensin II induces c-fos mRNA in aortic smooth muscle. J Biol Chem. 264:1989;526-530.
14. Naftilan AJ, Gilliland GK, Eldridge CS, Kraft AS Induction of the proto-oncogene c-jun by angiotensin II. Mol Cell Biol. 10:1990;5536-5540.
15. Naftilan AJ, Pratt RE, Dzau VJ Induction of the platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat smooth muscle cells. J Clin Invest. 83:1989;1419-1424.
16. Takasaki I, Chovanian AV, Sarzari R, Brecher P Effect of hypertension on fibronectin expression in the rat aorta. J Biol Chem. 265:1990;21935-21939.
17. Himeno H, Craword AC, Chovanian AV, Brecher P Angiotensin II alters aortic fibronectin independently of hypertension. Hypertension. 23(Part 2):1994;823-826.
18. Daeman MJ, Lombardi DM, Bosman FT, Schwartz SM Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 68:1991;450-456.
19. Viswanathan M, Stromberg C, Seltzer A, Saavedra JM Balloon angioplasty enhances the expression of angiotensin AT1 receptors in neointimaof rat aorta. J Clin Invest. 90:1992;1707-1712.
20. Rakugi H, Kim D-K, Krieger JE, Wang DS, Dzau VJ, Pratt RE Induction of angiotensin converting enzyme in the neointima after balloon injury. J Clin Invest. 93:1994;339-346.
21. Sakaguchi K, Chai S-Y, Jackson B, Johnston CI, Mendelsohn FAO Inhibition of tissue angiotensin converting enzyme: Quantitation by autoradiography. Hypertension. 11:1988;230-238.
22. Song K, Zhuo J, Allen AM, Paxinos G, Mendelsohn FAO Angiotensin II receptor subtypes in rat brain and peripheral tissues. Cardiology. 79(suppl 1):1991;45-54.
23. Shiota N, Okunishi H, Fikamizu A, Sakonjo H, Kikumori M, Nishimura T, Nakagawa T, Murakami K, Miyazaki M Activation of two angiotensin-generating systems in the balloon-injured artery. FEBS Lett. 323:1993;239-242.
24. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Wada T, Ishimura Y, Chatani F, Iwao H Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 24:1994;195-204.
25. Finberg AP, Vogelstein B A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 137:1983;266-267.
26. Qian SW, Kondaiah P, Roberts AB, Sporn MB cDNA cloning by PCR of rat transforming growth factor β-1. Nucleic Acids Res. 18:1990;3059.
27. Schwarzbauer JE, Tamkun JW, Lemischka IR, Hynes RO Three different fibronectin mRNA arise by alternative splicing within the codon region. Cell. 35:1983;421-431.
28. Genovese C, Rowe D, Kream B Construction of cDNA sequences complementary to rat α1 and α2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry. 23:1984;6210-6216.
29. Liau G, Yamada Y, Crombrugghe BD Cooridinate regulation of the levels of type III and type I collagen mRNA in most but not all mouse fibroblasts. J Biol Chem. 260:1985;531-536.
30. Fort PH, Marty L, Piechaczyk M, Sabrouty SEL, Dani CH, Jeanteur PH, Blanchard JM Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acid Res. 13:1985;1431-1442.
31. Haudenschild CC, Chovanian AV Blood pressure lowering diminishes age-related changes in the rat aortic intima. Hyertension. 6 (Suppl 1):1984;I62-I68.
32. MacMahon S. Blood pressure and the risk of cardiovascular disease. In: Swales SJ, editor. Textbook of hypertension. London, United Kingdam: Blackwell Scientific Publications 1994:46-57.
33. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science. 245:1989;186-188.
34. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye AM, Smith RD Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 45:1993;205-251.
35. Wiemer G, Scholkens BA, Becker RHA, Busse R Ramiprilat enhances endotherial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 18:1991;558-563.
36. Farhy RD, Carretero OA, Ho KL, Scicli AG Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on the neointima formation. Circ Res. 72:1993;1202-1210.
37. Kowala MC, Mazzucco CE, Hartl KS, Seiler SM, Warr GA, Abid S, Grove RI Prostacyclin agonists decreased early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42394 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production. Arterioscler Thromb. 13:1993;435-444.
38. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ML Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbits. J Clin Invest. 90:1992;1168-1172.
39. Kasid A, Bell GI, Director EP Effects of tranforming growth factor-β on human lymphokine-activated killer cell precursors: Autocrine inhibition of cellular proliferation and differentiation to immune killer cells. J Immunol. 14:1988;690-698.
40. Battegay EJ, Raines EW, Seifart RA, Bowen-Pope DF, Ross R TGF-β induces bimodal proliferation of connective tissue cell via complex control of an autocrine PDGF loop. Cell. 63:1990;515-524.
41. Majack RA Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol. 105:1987;465-471.
42. Roberts A, Sporn MB. The transforming growth factor-β. In peptide growth factors and their receptors. In: Sporn MG, Roberts AB, editors. Handbook of Experimental Pharmacology. Springe-Verlag, Heidelberg, Germany 1990;419-472.
43. Border WA, Rouslahti E Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest. 90:1992;1-7.
44. Rouslahti E Fibronectin and its receptor. Annu Rev Biochem. 57:1988;375-413.
45. Koibuchi Y, Lee WS, Gibbons GH, Pratt RE Transforming growth factor-β1 in the cellular growth response to angiotensin II. Hypertension. 21:1993;1046-1050.
46. 1 receptor-mediated stimulation by angiotensin II of rat aortic fibronrctin gene expression in vivo. Br J Pharmacol. 113:1994;662-663.
47. Johnston CI Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension. 23:1994;258-268.
48. Friedland J, Setton C, Silverstein Induction of angiotensin converting enzyme in human monocytes in culture. Biochem Biophys Res Commun. 83:1978;843-849.
49. Vuk-Pavlovic Z, Kreofsky TJ, Rohrbach MS Characteristics of monocyte angiotensin converting enzyme induction by dexamethasone. J Leukocyte Biol. 45:1989;503-509.
50. Diet F, Pratt RE, Berry GJ, Momosw N, Gibbons GH, Dzau VJ Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation. 94:1996;2756-2767.
51. 2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 95:1995;651-657.
52. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA. 92:1995;10663-10667.